Atorvastatin Calcium
Product Images NDC 43353-892
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 43353-892). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Bottle Label 80mg (43353 827)
Bottle Label 20mg (43353 892)
Aphena Pharma Solutions (TN)
Chemical Structure (Atorvastatin 01)
Figure 1 (Atorvastatin 02)
The text appears to be a graph showing the cumulative incidence percentage for a certain condition or event. The x-axis appears to be displaying the years while the y-axis displays the percentage. There are some numerical values marked within the graph points to indicate the incidence percentage at a certain year. Moreover, there are some texts written such as "Aovastatn" and "HR-084 050089", which may represent certain data or labels. The graph also shows a horizontal line marking 15% cumulative incidence and a vertical line at year 35. The text might be related to medical research and statistical data analysis.*
Figure 2 (Atorvastatin 03)
The text appears to be a table containing data on Cumulative Hazard (%), Atorvastatin, and the Time to the First Primary Endpaint Through Four (4) Years of Followsup (Years). It seems to be part of a larger analysis or report, but without additional context, it's difficult to provide a more detailed description of the data presented.*
Figure 3 (Atorvastatin 04)
The text appears to be a part of a study or clinical trial evaluating the effectiveness of two doses of statin, specifically, 10 mg and 80 mg of atorvastatin. The provided table shows the percentage of subjects experiencing an "E vert" (not clear what this refers to) for each dose of atorvastatin. Additionally, there is information on the hazard ratio and the time to the first major cardiovascular endpoint (in years).*
Greenstone Logo (Atorvastatin 05)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.